Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.
2.

Seed fixity in the prostate/periprostatic region following brachytherapy.

Merrick GS, Butler WM, Dorsey AT, Lief JH, Benson ML.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):215-20.

PMID:
10656395
3.

Reduction of radioactive seed embolization to the lung following prostate brachytherapy.

Tapen EM, Blasko JC, Grimm PD, Ragde H, Luse R, Clifford S, Sylvester J, Griffin TW.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1063-7.

PMID:
9869230
4.

Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.

Sugawara A, Nakashima J, Shigematsu N, Kunieda E, Kubo A.

Brachytherapy. 2009 Jan-Mar;8(1):52-6. doi: 10.1016/j.brachy.2008.10.003.

PMID:
19154979
5.

Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.

Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook J.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):61-8. doi: 10.1016/j.ijrobp.2008.04.009. Epub 2008 Sep 25.

PMID:
18823713
6.

Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.

Taussky D, Austen L, Toi A, Yeung I, Williams T, Pearson S, McLean M, Pond G, Crook J.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):974-80.

PMID:
15989997
7.

Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?

Potters L, Calugaru E, Jassal A, Presser J.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1014-9. Epub 2006 May 6.

PMID:
16682144
8.
9.

Implications of radioactive seed migration to the lungs after prostate brachytherapy.

Ankem MK, DeCarvalho VS, Harangozo AM, Hartanto VH, Perrotti M, Han Kr, Shih WJ, Malka E, White EC, Maggio R, Ioffreda R, Goldsmith JW, Weiss RE.

Urology. 2002 Apr;59(4):555-9.

PMID:
11927313
10.

Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction.

Zhu AX, Wallner KE, Frivold GP, Ferry D, Jutzy KR, Foster GP.

Brachytherapy. 2006 Oct-Dec;5(4):262-5.

PMID:
17118321
11.

Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds.

Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A, Mourtada F, Strasser J, Raben A.

Brachytherapy. 2013 Jul-Aug;12(4):356-61. doi: 10.1016/j.brachy.2013.01.163. Epub 2013 Mar 7.

PMID:
23477885
12.

The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.

Beaulieu L, Archambault L, Aubin S, Oral E, Taschereau R, Pouliot J.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1298-308.

PMID:
15001275
13.
14.

Cardiac and hepatic seed implant embolization after prostate brachytherapy.

Nguyen BD.

Urology. 2006 Sep;68(3):673.e17-9. Epub 2006 Sep 18.

PMID:
16979711
15.

Extraprostatic seed placement and its effect on seed loss.

Nedea E, Wallner K, Reed D, Ford E, Sutlief S, Mueller A, Maki J, Merrick G.

Cancer J. 2005 Mar-Apr;11(2):147-51.

PMID:
15969990
16.

A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.

Ali I, Algan O, Thompson S, Sindhwani P, Herman T, Cheng CY, Ahmad S.

Phys Med Biol. 2009 Sep 21;54(18):5595-611. doi: 10.1088/0031-9155/54/18/016. Epub 2009 Aug 28.

PMID:
19717887
17.

Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate.

Raben A, Sammons S, Sim S, Chen H, Hanlon A, Sarkar A, Donavanik V, Grebler A, Geltzeiler J, Benge B, Glick A, Jacob D, Koprowski P.

Brachytherapy. 2007 Oct-Dec;6(4):238-45.

PMID:
17991621
18.

Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.

Kunos CA, Resnick MI, Kinsella TJ, Ellis RJ.

Brachytherapy. 2004;3(2):71-7.

PMID:
15374538
19.

Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.

Williams SG, Millar JL, Duchesne GM, Dally MJ, Royce PL, Snow RM.

Radiother Oncol. 2004 Oct;73(1):33-8.

PMID:
15465143
20.

Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.

Raben A, Rusthoven KE, Sarkar A, Glick A, Benge B, Jacobs D, Raben D.

Brachytherapy. 2009 Jul-Sep;8(3):297-303. doi: 10.1016/j.brachy.2008.12.004. Epub 2009 Feb 12.

PMID:
19213608

Supplemental Content

Support Center